Would you like to purchase a DVD copy of this program?
Program Overview

Autism is a developmental disorder, typically presenting before the age of 3 years, which is characterized by impairments in communication and social interaction, as well as a restrictive, repetitive range of interests and activities. Once thought to be rare, it is now reported in 1 out of every 150 children. Research has shown that early detection and appropriate intervention can significantly improve functioning of the individual and reduce the need for lifelong interventions. Because the exact cause of autism remains unknown, medical therapy tends to focus on the comorbidities associated with autism.Through didactic presentations and a roundtable discussion of case studies, this educational program will provide pediatricians with a review of autism and focus on the latest trends in screening and the treatment of common comorbid conditions.

Learning Objectives
  • Describe autism as it relates to epidemiology, clinical presentations, evaluation, and differential diagnosis
  • Demonstrate knowledge and comfort in evaluating developmental status
  • Formulate developmental/behavioral assessments to incorporate into everyday practice and recognize the link between early screening and intervention with improved outcomes
  • Recognize the array of comorbidities that can present with autism and demonstrate knowledge of the pharmacologic agents most appropriate for these conditions
  • Explain the challenges of treating the neurobehavioral comorbidities of autism; formulate strategies to overcome these challenges and improve the care of patients with autism
  • Identify the unique pharmacologic considerations involved in treating individuals with autism


Rebecca Landa, PhD (Chair)
Director, Center for Autism and Related Disorders
Director, Research and Education for Autism in Children
Kennedy Krieger Institute Associate Professor of Psychiatry,
The Johns Hopkins School of Medicine
Baltimore, MD

Ann Reynolds, MD
Assistant Professor of Pediatrics, UCDHSC
The Child Development Unit,
The Children's Hospital
Denver, CO

James T. McCracken, MD
Joseph Campbell Professor of Child Psychiatry
Director, Division of Child and Adolescent Psychiatry
UCLA Semel Institute and Resnick Neuropsychiatric Hospital
Los Angeles, CA

Laura Schreibman, PhD
Distinguished Professor of Psychology
Director of the Autism Research Program
University of California, San Diego
San Diego, CA


Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continu-ing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: August 15, 2007. Expiration Date: August 15, 2009.

Estimated time to complete this activity: 2 hours.

No faculty member has indicated that their presentation will include information on off-label products.

Statement of Responsibility
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this activity.

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

Intended Audience
This program is designed for pediatricians. There are no prerequisites for attendees.

Full Disclosure Policy Affecting CME Activities
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a provider has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. To view presenting faculty disclosures, please refer to the disclosure slides at the beginning of the DVD presentation.

All rights reserved — The Johns Hopkins University School of Medicine.

Supported by an educational grant from Janssen, L.P.
administered by Ortho-McNeil Janssen Scientific Affairs, LLC.

Home | Contact Us | About Us | View Account | Need Help?